Now the Supreme Court might have done it for them.” That conclusion may have been overly optimistic, since misguided use of the P value continued unabated. Siracusano that investors could sue a drug company for failing to report adverse drug effects-even though they were not statistically significant.ĭescribing the case in the April 2, 2011, issue of the Wall Street Journal, Carl Bialik wrote, “A group of mathematicians has been trying for years to have a core statistical concept debunked. ![]() ![]() Supreme Court unanimously ruled in Matrixx Initiatives Inc.
0 Comments
Leave a Reply. |